Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac Disease

BACKGROUND: Autoantibodies against pancreatic secretory-granule membrane glycoprotein 2 (GP2) have been demonstrated in patients with Crohn’s disease but recently also with celiac disease (CD). Both entities are characterized by intestinal barrier impairment with increased gut permeability. Pathophy...

Descripción completa

Detalles Bibliográficos
Autores principales: Laass, Martin W., Röber, Nadja, Range, Ursula, Noß, Lydia, Roggenbuck, Dirk, Conrad, Karsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457647/
https://www.ncbi.nlm.nih.gov/pubmed/26047356
http://dx.doi.org/10.1371/journal.pone.0128104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457647/
https://www.ncbi.nlm.nih.gov/pubmed/26047356
http://dx.doi.org/10.1371/journal.pone.0128104

Ejemplares similares